Program:
Gene therapy, once thought to be the magic bullet, has recently come under criticism, in part because
of reliance on viral vectors. Synthetic vectors provide an attractive alternative, as they may offer
greater safety and the potential for repeated administration. However, further progress is still needed
for artificial self-assembling vectors to reach full potential for gene delivery. Progress has been made
in the improvement of transfection efficiency as well as targeting, duration, and level of gene
expression by the optimization of liposomes, development of dendrimers, and other novel structures.
The interaction of these artificial systems with genes, the factors determining which form of nucleic
acid as well as which delivery system may fit best with a given application, will be highlighted in this
meeting. The promise of this emerging therapeutic field will be addressed by early clinical trial results.
Plan now to attend and network with the top international researchers in the field of artificial
self-assembling vectors at this ground-breaking event.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164 USA
Phone: 617-630-1300
Fax: 617-630-1325
Deadline for Abstracts: September 12, 1997
Email for Requests and Registration: symposia@cambridge.org